Special items: Ovarian Cancer and Us blog best viewed in Firefox

Thursday, February 03, 2011

full free acPhase II Trial of Trastuzumab in Women with Advanced or Recurrent, HER2-Positive Endometrial Carcinoma: a Gynecologic Oncology Group Study


No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.